Procter & Gamble Company (The) $PG Stake Lessened by Fourpath Capital Management LLC

Fourpath Capital Management LLC lessened its stake in Procter & Gamble Company (The) (NYSE:PG) by 1.4% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 10,398 shares of the company’s stock after selling 149 shares during the period. Fourpath Capital Management LLC’s holdings in Procter & Gamble were worth $1,657,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Kingstone Capital Partners Texas LLC increased its stake in Procter & Gamble by 655,209.0% during the second quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock valued at $11,832,680,000 after purchasing an additional 76,017,350 shares during the last quarter. Northern Trust Corp increased its stake in Procter & Gamble by 0.8% during the first quarter. Northern Trust Corp now owns 29,644,000 shares of the company’s stock valued at $5,051,930,000 after purchasing an additional 248,792 shares during the last quarter. Price T Rowe Associates Inc. MD increased its stake in Procter & Gamble by 13.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock valued at $3,660,737,000 after purchasing an additional 2,466,308 shares during the last quarter. Goldman Sachs Group Inc. increased its stake in Procter & Gamble by 3.5% during the first quarter. Goldman Sachs Group Inc. now owns 17,405,539 shares of the company’s stock valued at $2,966,252,000 after purchasing an additional 583,629 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in Procter & Gamble by 6.3% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 17,293,428 shares of the company’s stock valued at $2,947,146,000 after purchasing an additional 1,018,865 shares during the last quarter. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Stock Performance

PG stock opened at $149.69 on Friday. The company has a market capitalization of $350.34 billion, a P/E ratio of 22.99, a PEG ratio of 3.99 and a beta of 0.36. The company has a 50-day simple moving average of $155.24 and a 200 day simple moving average of $159.53. Procter & Gamble Company has a fifty-two week low of $149.45 and a fifty-two week high of $180.43. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, topping the consensus estimate of $1.42 by $0.06. The business had revenue of $20.89 billion during the quarter, compared to the consensus estimate of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The company’s quarterly revenue was up 1.7% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.40 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Sell-side analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, insider Balaji Purushothaman sold 490 shares of the company’s stock in a transaction dated Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $74,592.70. Following the completion of the sale, the insider owned 12,616 shares of the company’s stock, valued at $1,920,533.68. This represents a 3.74% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CFO Andre Schulten sold 4,252 shares of the company’s stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $647,281.96. Following the completion of the sale, the chief financial officer directly owned 53,992 shares of the company’s stock, valued at $8,219,202.16. The trade was a 7.30% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 149,763 shares of company stock valued at $23,421,279. Corporate insiders own 0.20% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have weighed in on PG shares. BNP Paribas reiterated an “outperform” rating and set a $177.00 target price on shares of Procter & Gamble in a research note on Friday, August 15th. BNP Paribas Exane reduced their price target on shares of Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating for the company in a report on Tuesday, September 23rd. Berenberg Bank boosted their price target on shares of Procter & Gamble from $152.00 to $154.00 and gave the company a “hold” rating in a report on Wednesday, September 17th. Weiss Ratings reissued a “hold (c+)” rating on shares of Procter & Gamble in a report on Wednesday. Finally, Evercore ISI reissued an “in-line” rating and set a $170.00 price target (down previously from $190.00) on shares of Procter & Gamble in a report on Monday, July 14th. Eleven research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $172.21.

About Procter & Gamble

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.